Posts Tagged ‘Glaucoma’
New Injection Technology Sets the Standard for Icon BioSciences
William S. (Sandy) White, President & CEO for Icon BioSciences, discusses the company’s increasing portfolio of products that target most major therapeutic areas of ophthalmology. Stressing the importance of getting the correct drug, in the correct place, with the best clinical approach, Sandy details the progress of their latest products and briefly highlights their newest…
Read MoreAerie Advances to the Next Round in Glaucoma Treatment
Vicente Anido Jr. PhD, Chairman & CEO for Aerie Pharmaceuticals, provides the attendees of the 5th Annual Ophthalmology Innovation Summit with an overview of Aeries rapid changes throughout the past year. Aerie focuses on the treatment of Glaucoma and has two major products, AR-1324 and Latanapross. Having just completed their initial Public Offering, Aerie can…
Read MoreFunding Ophthalmology Innovation: The Focus of Science and Capital
Ophthalmology is a growing, but challenging, market. Innovation is abounding in its research stages and some people in the know foresee more positive development in breakthrough technologies by 2020, while delivering drugs to the back of the eye is up front in the minds and agendas of investors and innovators. Market data and dialogue indicate…
Read MoreOIS Sets Sights on Anterior Segment Innovations
The second annual Ophthalmology Innovation Summit (OIS) at the 2013 ASCRS•ASOA Symposium & Congress combined industry, clinicians, and entrepreneurs to highlight innovations in anterior segment surgery. The half-day session featured talks on the impact of femtosecond lasers and intraoperative aberrometry, as well as micro-invasive glaucoma surgery (MIGS). Co-chairman William J. Link, PhD, Versant Ventures, Menlo…
Read MoreClinical Overview of MIGS
Addressing the attendees at the 2nd Annual Ophthalmology Innovation Summit with a clinical overview of Micro-Invasive Glaucoma Surgery, Ike K. Ahmed, MD and Assistant Professor for the University of Toronto, details the transition from glaucoma medication to micro-invasive surgery and some of the devices contributing to the successes of this procedure. Presenter: Ike Ahmed, MD…
Read MoreIntroduction to MIGS: Micro-Invasive Glaucoma Surgery
Dr. Gil Kliman, Managing Director for InterWest Partners, introduces the conference’s segment on MIGS at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Giving the attendees an overview of the market and an in depth view of the different approaches, Gil sets the stage for further discussion around Micro-Invasive Glaucoma Surgery. Presenter: Gilbert…
Read More